Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The study aims to compare outcomes of Electroconvulsive Therapy (ECT) using ketamine versus
methohexital anesthesia in depressed patients. The investigators hypothesize that patients
who receive ketamine anesthesia during ECT will achieve remission status faster than those
receiving methohexital anesthesia. Also, at the end of the ECT course subjects will display
fewer cognitive side effects compared to those treated with methohexital anesthesia.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Alliance for Research on Schizophrenia and Depression